• 398 Citations
  • 11 h-Index
20082019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 9 Similar Profiles
Tuberculosis Medicine & Life Sciences
Meningeal Tuberculosis Medicine & Life Sciences
HIV Medicine & Life Sciences
Infection Medicine & Life Sciences
Latent Tuberculosis Medicine & Life Sciences
Isoniazid Medicine & Life Sciences
Rifampin Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2016 2019

Rifampin
HIV
Tuberculosis
Botswana
Research Personnel

Research Output 2008 2019

  • 398 Citations
  • 11 h-Index
  • 29 Article
  • 5 Review article
  • 4 Letter
  • 1 Editorial

Adipose tissue regulates pulmonary pathology during TB infection

Ayyappan, J. P., Ganapathi, U., Lizardo, K., Vinnard, C., Subbian, S., Perlin, D. & Nagajyothi, J., Mar 1 2019, In : mBio. 10, 2, e02771-18.

Research output: Contribution to journalArticle

Open Access
Mycobacterium tuberculosis
Adipose Tissue
Tuberculosis
Pathology
Lung

Attainment of target rifampicin concentrations in cerebrospinal fluid during treatment of tuberculous meningitis

Mezochow, A., Thakur, K. T., Zentner, I., Subbian, S., Kagan, L. & Vinnard, C., Jul 1 2019, In : International Journal of Infectious Diseases. 84, p. 15-21 7 p.

Research output: Contribution to journalArticle

Open Access
Meningeal Tuberculosis
Rifampin
Meningitis
Cerebrospinal Fluid
Tuberculosis

Dual β-lactam combinations highly active against mycobacterium abscessus complex in vitro

Pandey, R., Chen, L., Manca, C., Jenkins, S., Glaser, L., Vinnard, C., Stone, G., Lee, J., Mathema, B., Nuermberger, E. L., Bonomo, R. A. & Kreiswirth, B., Jan 1 2019, In : mBio. 10, 1, e02895-18.

Research output: Contribution to journalArticle

Open Access
Lactams
Ceftazidime
Mycobacterium
Imipenem
Anti-Bacterial Agents

Assessing response to therapy for nontuberculous mycobacterial lung disease: Quo vadis?

Vinnard, C., Mezochow, A., Oakland, H., Klingsberg, R., Hansen-Flaschen, J. & Hamilton, K., Nov 20 2018, In : Frontiers in Microbiology. 9, NOV, 02813.

Research output: Contribution to journalReview article

Lung Diseases
Biomarkers
Therapeutics
Pharmaceutical Preparations
Standard of Care
5 Citations (Scopus)

Effect of Mycobacterium tuberculosis infection on adipocyte physiology

Ayyappan, J. P., Vinnard, C., Subbian, S. & Nagajyothi, J. F., Feb 1 2018, In : Microbes and Infection. 20, 2, p. 81-88 8 p.

Research output: Contribution to journalArticle

Mycobacterium Infections
Mycobacterium tuberculosis
Adipocytes
Adipose Tissue
Lung